|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07J 63/00 | |
| A61K 31/575 | |||
| A61P 25/28 | |||
| A61P 9/10 |
| (11) | Patento numeris | 3365351 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17790966.0 |
| Europos patento paraiškos padavimo data | 2017-10-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-08-29 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-12-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2017/075042 |
| Data | 2017-10-03 |
| (87) | Numeris | WO 2018/069086 |
| Data | 2018-04-19 |
| (30) | Numeris | Data | Šalis |
| 16193684 | 2016-10-13 | EP |
| (72) |
MUŃOZ BLANCO, Eduardo, ES
MINASSI, Alberto, IT
BELLIDO CABELLO DE ALBA, Mar a Luz, ES
APPENDINO, Giovanni, IT
|
| (73) |
Vivacell Biotechnology Espana S.L.,
Parque Cient fico Tecnol gico de C rdoba Rabanales 21 C/ Astr noma Cecilia Payne Parcela ID 8.1 Edificio Centauro 1 Planta, 14014 C rdoba,
ES
|
| (54) | HYDROXAMATE TRITERPENOID DERIVATIVES |
| HYDROXAMATE TRITERPENOID DERIVATIVES |